Bio Products Laboratory Limited: medicines

Loading your page…

Sources and licences

Medicine	Substance	Country	Status	Authorised
Albuminex12.5g/50ml · Solution	Albumin	United States	Marketed	2018
Albuminex25g/100ml · Solution	Albumin	United States	Marketed	2018
Albuminex25g/500ml · Solution	Albumin	United States	Marketed	2018
Albuminex12.5g/250ml · Solution	Albumin	United States	Marketed	2018
Coagadex500iu · For Injection	Coagulation factor x	United States	Marketed	2015
Coagadex250iu · For Injection	Coagulation factor x	United States	Marketed	2015
Gammaplex20g/200ml · Injection	Immune globulin intravenous	United States	Marketed	2017
Gammaplex20g/400ml · Injection	Immune globulin intravenous	United States	Not marketed	2014
Gammaplex5g/50ml · Injection	Immune globulin intravenous	United States	Marketed	2017
Gammaplex10g/200ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex2.5g/50ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex5g/100ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex10g/100ml · Injection	Immune globulin intravenous	United States	Marketed	2017
OPTIVATE 100 UI/ml100UI/ml · Pulb. + solv. pt. sol. inj.	Factor viii coagulare si factor von willebrand	Romania	unknown

Medicine	Substance	Country	Status	Authorised
Albuminex12.5g/50ml · Solution	Albumin	United States	Marketed	2018
Albuminex25g/100ml · Solution	Albumin	United States	Marketed	2018
Albuminex25g/500ml · Solution	Albumin	United States	Marketed	2018
Albuminex12.5g/250ml · Solution	Albumin	United States	Marketed	2018
Coagadex500iu · For Injection	Coagulation factor x	United States	Marketed	2015
Coagadex250iu · For Injection	Coagulation factor x	United States	Marketed	2015
Gammaplex20g/200ml · Injection	Immune globulin intravenous	United States	Marketed	2017
Gammaplex20g/400ml · Injection	Immune globulin intravenous	United States	Not marketed	2014
Gammaplex5g/50ml · Injection	Immune globulin intravenous	United States	Marketed	2017
Gammaplex10g/200ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex2.5g/50ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex5g/100ml · Injection	Immune globulin intravenous	United States	Not marketed	2009
Gammaplex10g/100ml · Injection	Immune globulin intravenous	United States	Marketed	2017
OPTIVATE 100 UI/ml100UI/ml · Pulb. + solv. pt. sol. inj.	Factor viii coagulare si factor von willebrand	Romania	unknown

Country	Medicines	Current	Past	Companies
United States	13	13	0	Companies All medicines
Romania	1	0	1	Companies All medicines

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Anvisa, Brazil

Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.

Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions

Health Canada, Canada

Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 register, published 7 October 2026; https://assets.publishing.service.gov.uk/media/6ac660fdec9d3aba1e0139d9/MS_Register_-_October_2026.csv; acquired 2026-10-13T22:59:02.704630+00:00; CSV-to-role/site projection is an adaptation under Open Government Licence v3.0.

Licence: Open Government Licence v3.0; Crown copyright MHRA factual register

Ministerul Sănătății

Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.

Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)

All 8 sources

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence

U.S. Food and Drug Administration

FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.

Licence: FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions

Report an error or request removalCorrections from the company itself are welcome.

Bio Products Laboratory Limited

Medicines

Know your medicines, with the sources.

Bio Products Laboratory Limited

Medicines

Know your medicines, with the sources.

Countries

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

United Kingdom: more companies